Experience with mobile inhaled nitric oxide during transport of neonates and children with respiratory insufficiency to an extracorporeal membrane oxygenation center

Claire Westrope, Neil Roberts, Sanjiv Nichani, Carmel Hunt, Giles J. Peek, Richard Firmin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: To share our experience with the use of inhaled nitric oxide (iNO) during the transport of ventilated neonates and children to an extracorporeal membrane oxygenation (ECMO) center and to discuss the efficacy and safety of iNO use in this situation. Data Sources: Case note review of 55 consecutive patients transported while receiving iNO to Glenfield Hospital, Leicester, UK, for consideration of ECMO. Study Selection: Retrospective case note review. Data Extraction: The clinical condition of each patient recorded at arrival of the transport team at the referring hospital, during transport, and at arrival at Glenfield Hospital. Preclinical and postclinical conditions were compared using the paired Student's t-test. Data Synthesis: Overall data showed a significant improvement in transcutaneous oximetry measurements (SpO2: 84.8% preclinical, 90.6% postclinical; p= .006) and PaO2 (59 torr [7.87 kPa] preclinical, 84 torr [11.23 kPa] postclinical; p- .001) during transport in our patient group. Based on limited safety data, no untoward events or toxic metabolites were observed with iNO therapy during transport. Conclusions: iNO does appear to improve oxygenation during transfer of patients for ECMO in our series. Based on limited safety data, iNO appears safe to use in transport. (Pediatr Crit Care Med 2004; 5:542-546)

Original languageEnglish (US)
Pages (from-to)542-546
Number of pages5
JournalPediatric Critical Care Medicine
Volume5
Issue number6
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Respiratory Insufficiency
Nitric Oxide
Newborn Infant
Safety
Transcutaneous Blood Gas Monitoring
Patient Transfer
Poisons
Information Storage and Retrieval
Retrospective Studies
Students

Keywords

  • Children
  • Extracorporeal membrane oxygenation
  • Inhaled nitric oxide
  • Neonates
  • Transport

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Critical Care and Intensive Care Medicine

Cite this

Experience with mobile inhaled nitric oxide during transport of neonates and children with respiratory insufficiency to an extracorporeal membrane oxygenation center. / Westrope, Claire; Roberts, Neil; Nichani, Sanjiv; Hunt, Carmel; Peek, Giles J.; Firmin, Richard.

In: Pediatric Critical Care Medicine, Vol. 5, No. 6, 2004, p. 542-546.

Research output: Contribution to journalArticle

@article{9d6b3d9c3d1a4681965c61ba9eb61020,
title = "Experience with mobile inhaled nitric oxide during transport of neonates and children with respiratory insufficiency to an extracorporeal membrane oxygenation center",
abstract = "Objective: To share our experience with the use of inhaled nitric oxide (iNO) during the transport of ventilated neonates and children to an extracorporeal membrane oxygenation (ECMO) center and to discuss the efficacy and safety of iNO use in this situation. Data Sources: Case note review of 55 consecutive patients transported while receiving iNO to Glenfield Hospital, Leicester, UK, for consideration of ECMO. Study Selection: Retrospective case note review. Data Extraction: The clinical condition of each patient recorded at arrival of the transport team at the referring hospital, during transport, and at arrival at Glenfield Hospital. Preclinical and postclinical conditions were compared using the paired Student's t-test. Data Synthesis: Overall data showed a significant improvement in transcutaneous oximetry measurements (SpO2: 84.8{\%} preclinical, 90.6{\%} postclinical; p= .006) and PaO2 (59 torr [7.87 kPa] preclinical, 84 torr [11.23 kPa] postclinical; p- .001) during transport in our patient group. Based on limited safety data, no untoward events or toxic metabolites were observed with iNO therapy during transport. Conclusions: iNO does appear to improve oxygenation during transfer of patients for ECMO in our series. Based on limited safety data, iNO appears safe to use in transport. (Pediatr Crit Care Med 2004; 5:542-546)",
keywords = "Children, Extracorporeal membrane oxygenation, Inhaled nitric oxide, Neonates, Transport",
author = "Claire Westrope and Neil Roberts and Sanjiv Nichani and Carmel Hunt and Peek, {Giles J.} and Richard Firmin",
year = "2004",
doi = "10.1097/01.PCC.0000137338.27059.C7",
language = "English (US)",
volume = "5",
pages = "542--546",
journal = "Pediatric Critical Care Medicine",
issn = "1529-7535",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Experience with mobile inhaled nitric oxide during transport of neonates and children with respiratory insufficiency to an extracorporeal membrane oxygenation center

AU - Westrope, Claire

AU - Roberts, Neil

AU - Nichani, Sanjiv

AU - Hunt, Carmel

AU - Peek, Giles J.

AU - Firmin, Richard

PY - 2004

Y1 - 2004

N2 - Objective: To share our experience with the use of inhaled nitric oxide (iNO) during the transport of ventilated neonates and children to an extracorporeal membrane oxygenation (ECMO) center and to discuss the efficacy and safety of iNO use in this situation. Data Sources: Case note review of 55 consecutive patients transported while receiving iNO to Glenfield Hospital, Leicester, UK, for consideration of ECMO. Study Selection: Retrospective case note review. Data Extraction: The clinical condition of each patient recorded at arrival of the transport team at the referring hospital, during transport, and at arrival at Glenfield Hospital. Preclinical and postclinical conditions were compared using the paired Student's t-test. Data Synthesis: Overall data showed a significant improvement in transcutaneous oximetry measurements (SpO2: 84.8% preclinical, 90.6% postclinical; p= .006) and PaO2 (59 torr [7.87 kPa] preclinical, 84 torr [11.23 kPa] postclinical; p- .001) during transport in our patient group. Based on limited safety data, no untoward events or toxic metabolites were observed with iNO therapy during transport. Conclusions: iNO does appear to improve oxygenation during transfer of patients for ECMO in our series. Based on limited safety data, iNO appears safe to use in transport. (Pediatr Crit Care Med 2004; 5:542-546)

AB - Objective: To share our experience with the use of inhaled nitric oxide (iNO) during the transport of ventilated neonates and children to an extracorporeal membrane oxygenation (ECMO) center and to discuss the efficacy and safety of iNO use in this situation. Data Sources: Case note review of 55 consecutive patients transported while receiving iNO to Glenfield Hospital, Leicester, UK, for consideration of ECMO. Study Selection: Retrospective case note review. Data Extraction: The clinical condition of each patient recorded at arrival of the transport team at the referring hospital, during transport, and at arrival at Glenfield Hospital. Preclinical and postclinical conditions were compared using the paired Student's t-test. Data Synthesis: Overall data showed a significant improvement in transcutaneous oximetry measurements (SpO2: 84.8% preclinical, 90.6% postclinical; p= .006) and PaO2 (59 torr [7.87 kPa] preclinical, 84 torr [11.23 kPa] postclinical; p- .001) during transport in our patient group. Based on limited safety data, no untoward events or toxic metabolites were observed with iNO therapy during transport. Conclusions: iNO does appear to improve oxygenation during transfer of patients for ECMO in our series. Based on limited safety data, iNO appears safe to use in transport. (Pediatr Crit Care Med 2004; 5:542-546)

KW - Children

KW - Extracorporeal membrane oxygenation

KW - Inhaled nitric oxide

KW - Neonates

KW - Transport

UR - http://www.scopus.com/inward/record.url?scp=21644480189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21644480189&partnerID=8YFLogxK

U2 - 10.1097/01.PCC.0000137338.27059.C7

DO - 10.1097/01.PCC.0000137338.27059.C7

M3 - Article

VL - 5

SP - 542

EP - 546

JO - Pediatric Critical Care Medicine

JF - Pediatric Critical Care Medicine

SN - 1529-7535

IS - 6

ER -